Javascript must be enabled to continue!
Prenatal sonographic diagnosis of Neu‐Laxova syndrome
View through CrossRef
AbstractWe report the sonographic diagnosis of Neu‐Laxova syndrome in a fetus at 27 weeks' menstrual age. The parents were first cousins. Sonography revealed microcephaly, a sloping forehead, exophthalmos, a small thorax and abdomen, hypoplastic lungs, syndactyly, hyperextended knees, polyhydramnios, a small placenta, and intrauterine growth restriction. The long bones were normal. The calvaria was hyperechoic and associated with shadowing, obscuring any intracranial abnormalities. This sonographic finding was presumed to represent calvarial calcification, not previously described with this syndrome. We believe that Neu‐Laxova syndrome can be reliably diagnosed prenatally by demonstrating the sonographic features described, although other conditions with similar sonographic features need to be considered in the differential diagnosis. © 2001 John Wiley & Sons, Inc. J Clin Ultrasound 29:531–534, 2001.
Title: Prenatal sonographic diagnosis of Neu‐Laxova syndrome
Description:
AbstractWe report the sonographic diagnosis of Neu‐Laxova syndrome in a fetus at 27 weeks' menstrual age.
The parents were first cousins.
Sonography revealed microcephaly, a sloping forehead, exophthalmos, a small thorax and abdomen, hypoplastic lungs, syndactyly, hyperextended knees, polyhydramnios, a small placenta, and intrauterine growth restriction.
The long bones were normal.
The calvaria was hyperechoic and associated with shadowing, obscuring any intracranial abnormalities.
This sonographic finding was presumed to represent calvarial calcification, not previously described with this syndrome.
We believe that Neu‐Laxova syndrome can be reliably diagnosed prenatally by demonstrating the sonographic features described, although other conditions with similar sonographic features need to be considered in the differential diagnosis.
© 2001 John Wiley & Sons, Inc.
J Clin Ultrasound 29:531–534, 2001.
Related Results
neu Antigen-Negative Variants Can Be Generated after neu-Specific Antibody Therapy in neu Transgenic Mice
neu Antigen-Negative Variants Can Be Generated after neu-Specific Antibody Therapy in neu Transgenic Mice
Abstract
Prolonged administration of HER-2/neu-specific monoclonal antibody therapy is now widely used for the treatment of HER-2/neu-overexpressing tumors in advanc...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Prenatal Course and Sonographic Features of Congenital Mesoblastic Nephroma
Prenatal Course and Sonographic Features of Congenital Mesoblastic Nephroma
Background: Congenital mesoblastic nephroma (CMN) is the most common renal tumor among fetuses and infants before the age of 6 months. It usually behaves as a benign tumor. The pre...
Vaccination against the HER-2/neu oncogenic protein.
Vaccination against the HER-2/neu oncogenic protein.
The HER-2/neu oncogenic protein is a well-defined tumor antigen. HER-2/neu is a shared antigen among multiple tumor types. Patients with HER-2/neu protein-overexpressing breast, ov...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract
Introduction
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
Παραγωγή κυτταροτοξικών κυττάρων γενετικά τροποποιημένων ώστε να αναγνωρίζουν την HER-2/neu ογκοπρωτεΐνη, μέσω χιμαιρικών υποδοχέων
Παραγωγή κυτταροτοξικών κυττάρων γενετικά τροποποιημένων ώστε να αναγνωρίζουν την HER-2/neu ογκοπρωτεΐνη, μέσω χιμαιρικών υποδοχέων
Η HER-2/neu ογκοπρωτεΐνη υπερεκφράζεται σε πολλά είδη καρκίνου στον άνθρωπο. Έχει αποδειχθεί ότι αυτό σχετίζεται με αυξημένη μεταστατική ικανότητα και μειωμένη πρόγνωση. Επιπρόσθετ...
Prenatal DEHP exposure induces lifelong testicular toxicity by continuously interfering with steroidogenic gene expression
Prenatal DEHP exposure induces lifelong testicular toxicity by continuously interfering with steroidogenic gene expression
Abstract
Epidemiologic studiessuggested the association between prenatal Di-(2-ethylhexyl) phthalate (DEHP) exposure and disorders of sex development (DSD), adult male diso...
Modelling Prenatal Care Pathways at a Central Hospital in Zimbabwe
Modelling Prenatal Care Pathways at a Central Hospital in Zimbabwe
Background: Maternal mortality remains a problem in low-income countries (LICs). In Zimbabwe, there has been an unprecedented increase in maternal mortality in the last 2.5 decades...

